Groupe Bruxelles Lambert reported 1 positions worth $62.16M for the quarter ended Jun 30, 2026, down 74.1% on the prior quarter. It opened 0 new positions, added to 0, trimmed 1 and exited 0. Its largest holding is Concentrix Corp at 100% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
No positions were added to this quarter.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| CNXC Concentrix Corp | -6.00M | -68.4% | $134.46M | 100% |
No new positions this quarter.
No positions were closed this quarter.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | CNXC Concentrix Corp | Industrials | 2.77M | $62.16M | 100% | -6.00M | -68.4% | Reduced | 4.56% |
Tip. Select a row to see that position’s full history at Groupe Bruxelles Lambert.
As of its Q2 2026 13F filing, Groupe Bruxelles Lambert’s five largest positions were Concentrix Corp (CNXC) at 100.0% of the reported portfolio.
Groupe Bruxelles Lambert reported a 13F portfolio worth $62.16M across 1 positions for Q2 2026. That is down 74.1% from the previous quarter.
Its largest sales by value were Concentrix Corp ($134.46M). It exited 0 positions entirely.
From the Form 13F-HR reports Groupe Bruxelles Lambert files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.